L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	153,513	132,181	202,956	107,379	143,972	505,923
Market Cap Growth	-27.18%	-34.87%	89.01%	-25.42%	-71.54%	592.81%
Enterprise Value	153,147	129,243	200,512	115,624	150,234	520,503
Last Close Price	7700.00	6630.00	10180.00	7212.36	9679.51	35296.46
PE Ratio	30.25	13.57	-	-	-	-
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	4.28	3.66	6.79	5.43	9.37	26.14
PB Ratio	4.12	3.67	6.64	9.98	5.81	14.81
P/TBV Ratio	3.58	3.19	5.87	9.29	6.19	16.57
EV/Sales Ratio	4.27	3.58	6.71	5.85	9.77	26.89
EV/EBITDA Ratio	42.55	22.88	46.12	-	-	-
EV/EBIT Ratio	156.39	41.99	98.58	-	-	-
Debt / Equity Ratio	0.65	0.65	0.44	2.34	0.91	0.59
Debt / EBITDA Ratio	6.20	4.14	3.11	-	-	-
Asset Turnover	0.50	0.50	0.52	0.35	0.26	0.30
Inventory Turnover	0.26	0.27	0.24	0.33	0.48	0.31
Quick Ratio	0.86	0.90	1.04	0.50	1.70	0.59
Current Ratio	1.64	1.63	1.95	0.95	3.01	1.63
Return on Equity (ROE)	19.41%	27.47%	-25.34%	-91.33%	-46.30%	-30.56%
Return on Assets (ROA)	1.11%	2.64%	2.20%	-14.22%	-16.15%	-3.69%
Return on Capital (ROIC)	1.51%	3.72%	3.18%	-19.14%	-18.84%	-4.16%
Return on Capital Employed (ROCE)	2.80%	7.00%	5.10%	-	-	-
Earnings Yield	3.63%	7.37%	-0.92%	-12.69%	-6.72%	-2.12%
FCF Yield	-5.26%	-6.06%	-1.68%	-6.22%	-7.29%	-0.54%
Buyback Yield / Dilution	-21.17%	-32.67%	-21.04%	-0.07%	-12.57%	-14.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.